LISAvienna: No silly season in Vienna

This time, our newsletter covers stories from A like AFFiRiS to Z like Zytoprotec.

Fresh money, milestones in the clinical development of novel drugs and medical products, new agreements and press releases about seminal new infrastructures such as a CD lab or a new proteomics facility are included. Additionally, a preview of the international professional events LISAvienna will soon participate in, is enclosed. Also make a note of the upcoming funding deadlines we remind of. In this regard, also make use of our webpage as a resources for your searches and consider the Horizon2020 calls published end of July.

In our e-newsletter, you will also find a link to a new article that has been written in the context of our collaboration with Chemiereport. It focuses on novel cancer therapeutics made in Vienna.

Enjoy reading the current edition

Register now for LISAvienna’s e-newsletter

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)